eilatine has been researched along with 1,7-phenanthroline in 11 studies
| Studies (eilatine) | Trials (eilatine) | Recent Studies (post-2010) (eilatine) | Studies (1,7-phenanthroline) | Trials (1,7-phenanthroline) | Recent Studies (post-2010) (1,7-phenanthroline) |
|---|---|---|---|---|---|
| 13 | 0 | 1 | 5,049 | 37 | 1,338 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amiel, A; Einat, M; Fabian, I; Kashman, Y; Lishner, M; Markel, D; Nagler, A; Rudi, A; Yarkorli, S | 1 |
| Amiel, A; Einat, M; Fabian, I; Fejgin, MD; Kashman, Y; Nagler, A; Rudi, A | 1 |
| Einat, M; Fabian, I; Nagler, A; Toren, A | 1 |
| Goldberg, I; Gut, D; Kol, M; Kopilov, J; Rudi, A | 1 |
| Glazer, EC; Gut, D; Hwang, JS; Kol, M; Luedtke, NW; Tor, Y | 1 |
| Goldberg, I; Gut, D; Kol, M | 1 |
| Luedtke, NW; Tor, Y | 1 |
| Gut, D; Hwang, JS; Kol, M; Luedtke, NW; Nava, E; Tor, Y | 1 |
| Bergman, SD; Cohen, Y; Frish, L; Goldberg, I; Kol, M; Reshef, D | 1 |
| Barbieri, A; Bergman, SD; Goldberg, I; Kol, M | 1 |
| Bouffier, L; Debray, J; Demeunynck, M; Dinica, R; Dumy, P | 1 |
1 review(s) available for eilatine and 1,7-phenanthroline
| Article | Year |
|---|---|
Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
Topics: Amino Acid Sequence; Anisotropy; Anti-HIV Agents; Base Sequence; Binding Sites; Biophysical Phenomena; Biophysics; CD4 Antigens; Dose-Response Relationship, Drug; Ethidium; Gene Products, rev; Inhibitory Concentration 50; Intercalating Agents; Kinetics; Ligands; Models, Biological; Models, Chemical; Molecular Sequence Data; Nucleic Acid Conformation; Open Reading Frames; Peptides; Phenanthrolines; Protein Binding; Response Elements; RNA; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid; Spectrometry, Fluorescence | 2003 |
10 other study(ies) available for eilatine and 1,7-phenanthroline
| Article | Year |
|---|---|
Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Agents; Bone Marrow; Cell Division; Cell Survival; Child; Child, Preschool; Cytarabine; Female; Hematopoietic Stem Cells; Humans; In Situ Hybridization, Fluorescence; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Phenanthrolines; Tumor Cells, Cultured | 1995 |
Synergistic effects of interleukin-11 with other growth factors on the expansion of hematopoietic progenitors from normal individuals and chronic myeloid leukemia patients resistant to treatment with cytosine arabinoside or eilatin.
Topics: Animals; Antineoplastic Agents; CHO Cells; Cricetinae; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Interleukin-11; Interleukin-3; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phenanthrolines; Stem Cell Factor; Tumor Stem Cell Assay | 1996 |
Human umbilical cord blood myeloid progenitor cells are relatively chemoresistant: a potential model for autologous transplantations in HIV-infected newborns.
Topics: Antiviral Agents; Bone Marrow Cells; Cell Division; Cells, Cultured; Colony-Forming Units Assay; Cytarabine; Drug Resistance; Female; Fetal Blood; Flow Cytometry; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; HIV Infections; Humans; Infant, Newborn; Interferon-alpha; Models, Biological; Phenanthrolines; Transplantation, Autologous; Zidovudine | 1997 |
Pairing of propellers: dimerization of octahedral ruthenium(II) and osmium(II) complexes of eilatin via pi-pi stacking featuring heterochiral recognition.
Topics: Alkaloids; Dimerization; Kinetics; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Organometallic Compounds; Osmium; Phenanthrolines; Ruthenium | 2002 |
Eilatin Ru(II) complexes display anti-HIV activity and enantiomeric diversity in the binding of RNA.
Topics: Amino Acid Sequence; Base Sequence; Binding, Competitive; DNA; Dose-Response Relationship, Drug; Ethidium; Genes, env; HeLa Cells; HIV-1; Humans; Molecular Sequence Data; Organometallic Compounds; Phenanthrolines; Protein Binding; RNA; Ruthenium; Stereoisomerism; Transcriptional Activation | 2002 |
Eilatin as a bridging ligand in ruthenium(II) complexes: synthesis, crystal structures, absorption spectra, and electrochemical properties.
Topics: Alkaloids; Crystallography, X-Ray; Electrochemistry; Ligands; Magnetic Resonance Spectroscopy; Molecular Conformation; Molecular Structure; Organometallic Compounds; Phenanthrolines; Ruthenium | 2003 |
The DNA and RNA specificity of eilatin Ru(II) complexes as compared to eilatin and ethidium bromide.
Topics: Base Sequence; Biopolymers; DNA; Ethidium; Intercalating Agents; Macromolecular Substances; Molecular Sequence Data; Organometallic Compounds; Phenanthrolines; RNA; Viscosity | 2003 |
From eilatin to isoeilatin: a skeletal rearrangement strongly influences pi-stacking of Ru(II) complex.
Topics: Alkaloids; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Organometallic Compounds; Phenanthrolines; Ruthenium; Stereoisomerism | 2004 |
Mononuclear and dinuclear complexes of isoeilatin.
Topics: Alkaloids; Electrochemistry; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Organometallic Compounds; Osmium; Oxidation-Reduction; Phenanthrolines; Ruthenium | 2005 |
Functionalization of the A ring of pyridoacridine as a route toward greater structural diversity. Synthesis of an octacyclic analogue of eilatin.
Topics: Acridines; Cell Line, Tumor; Cytostatic Agents; Heterocyclic Compounds, 4 or More Rings; Humans; Phenanthrolines; Stereoisomerism | 2009 |